SK279329B6 - Stabilný hydratovaný suchý práškový cefalosporínov - Google Patents

Stabilný hydratovaný suchý práškový cefalosporínov Download PDF

Info

Publication number
SK279329B6
SK279329B6 SK1311-94A SK131194A SK279329B6 SK 279329 B6 SK279329 B6 SK 279329B6 SK 131194 A SK131194 A SK 131194A SK 279329 B6 SK279329 B6 SK 279329B6
Authority
SK
Slovakia
Prior art keywords
ceftibuten
water
suspension
trihydrate
sweetener
Prior art date
Application number
SK1311-94A
Other languages
English (en)
Slovak (sk)
Other versions
SK131194A3 (en
Inventor
Donald A. Johnson
Lorraine Wearley
Rebecca Galeos
Joel A. Sequeira
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of SK131194A3 publication Critical patent/SK131194A3/sk
Publication of SK279329B6 publication Critical patent/SK279329B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
SK1311-94A 1992-04-30 1993-04-30 Stabilný hydratovaný suchý práškový cefalosporínov SK279329B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87688192A 1992-04-30 1992-04-30
PCT/US1993/003856 WO1993021923A1 (en) 1992-04-30 1993-04-30 Stable hydrated cephalosporin dry powder for oral suspension formulation

Publications (2)

Publication Number Publication Date
SK131194A3 SK131194A3 (en) 1995-07-11
SK279329B6 true SK279329B6 (sk) 1998-10-07

Family

ID=25368763

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1311-94A SK279329B6 (sk) 1992-04-30 1993-04-30 Stabilný hydratovaný suchý práškový cefalosporínov

Country Status (23)

Country Link
US (1) US5599557A (de)
EP (1) EP0642344B1 (de)
JP (1) JP3378004B2 (de)
KR (1) KR100257803B1 (de)
AT (1) ATE150310T1 (de)
AU (1) AU674516B2 (de)
CA (1) CA2134467A1 (de)
CZ (1) CZ283428B6 (de)
DE (1) DE69309052T2 (de)
DK (1) DK0642344T3 (de)
EE (1) EE03039B1 (de)
ES (1) ES2099438T3 (de)
FI (1) FI945081A0 (de)
GR (1) GR3023516T3 (de)
HK (1) HK1002407A1 (de)
HU (1) HU215958B (de)
NO (1) NO307594B1 (de)
NZ (1) NZ252433A (de)
PL (1) PL171630B1 (de)
RU (1) RU2123863C1 (de)
SK (1) SK279329B6 (de)
UA (1) UA27899C2 (de)
WO (1) WO1993021923A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US8313775B2 (en) * 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
US8313776B2 (en) * 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005016311A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
JP2007502294A (ja) * 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1658034A4 (de) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
JP2007513869A (ja) * 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
WO2005062898A2 (en) * 2003-12-24 2005-07-14 Advancis Pharmaceutical Corporation Enhanced absorption of modified release dosage forms
JP2008505124A (ja) * 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US8653145B2 (en) * 2005-09-22 2014-02-18 Eaton Scientific Systems, Ltd. Method for alleviating climacteric symptoms
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20100048609A1 (en) * 2006-08-01 2010-02-25 Jacobs Jeffrey W Pharmaceutical dosage forms for (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
FR2911506B1 (fr) * 2007-01-18 2009-07-03 Ceva Sante Animale Sa Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en) 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
JP5343002B2 (ja) * 2007-06-22 2013-11-13 株式会社カネカ 生理活性物質含有組成物
JP5364580B2 (ja) * 2007-08-22 2013-12-11 株式会社カネカ 還元型補酵素ｑ１０の製造方法、ならびに、その安定化方法
EP2566449B1 (de) * 2010-05-04 2014-10-08 Mahmut Bilgic Pharmazeutische zusammensetzungen mit ceftibuten
RU2550932C1 (ru) * 2014-03-18 2015-05-20 Александр Александрович Кролевец Способ получения нанокапсул цефалоспориновых антибиотиков в ксантановой камеди

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549746A (en) * 1967-11-02 1970-12-22 Bristol Myers Co Antibiotic composition
US3780195A (en) * 1969-10-22 1973-12-18 Balchem Corp Encapsulation process
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
NZ220764A (en) * 1986-07-02 1989-09-27 Shionogi & Co Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
US4803082A (en) * 1987-10-28 1989-02-07 Warner-Lambert Company Flavor and sweetness enhancement delivery systems and method of preparation
US5112604A (en) * 1989-09-01 1992-05-12 Riker Laboratories, Inc. Oral suspension formulation

Also Published As

Publication number Publication date
SK131194A3 (en) 1995-07-11
UA27899C2 (uk) 2000-10-16
EP0642344A1 (de) 1995-03-15
HU215958B (hu) 1999-03-29
DE69309052T2 (de) 1997-06-19
FI945081A (fi) 1994-10-28
CZ263694A3 (en) 1995-04-12
KR950701224A (ko) 1995-03-23
CZ283428B6 (cs) 1998-04-15
AU4115293A (en) 1993-11-29
JPH07506366A (ja) 1995-07-13
CA2134467A1 (en) 1993-11-11
DK0642344T3 (da) 1997-07-07
HU9403108D0 (en) 1995-02-28
EP0642344B1 (de) 1997-03-19
JP3378004B2 (ja) 2003-02-17
RU94046038A (ru) 1996-11-10
NZ252433A (en) 1996-07-26
EE03039B1 (et) 1997-10-15
ATE150310T1 (de) 1997-04-15
AU674516B2 (en) 1997-01-02
PL171630B1 (pl) 1997-05-30
US5599557A (en) 1997-02-04
ES2099438T3 (es) 1997-05-16
WO1993021923A1 (en) 1993-11-11
RU2123863C1 (ru) 1998-12-27
NO944113D0 (no) 1994-10-28
HK1002407A1 (en) 1998-08-21
FI945081A0 (fi) 1994-10-28
NO307594B1 (no) 2000-05-02
NO944113L (no) 1994-10-28
GR3023516T3 (en) 1997-08-29
DE69309052D1 (de) 1997-04-24
HUT71226A (en) 1995-11-28
KR100257803B1 (en) 2000-08-01

Similar Documents

Publication Publication Date Title
SK279329B6 (sk) Stabilný hydratovaný suchý práškový cefalosporínov
US4321253A (en) Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
KR100354310B1 (ko) 아지스로마이신투여방법
US4676984A (en) Rehydratable antacid composition
RU2205639C2 (ru) Фармацевтический суспензионный препарат, содержащий амоксициллин, клавулановую кислоту и целлюлозу
JPH0219091B2 (de)
JP3480939B2 (ja) アモキシシリンおよびクラブラン酸含有の組成物
US20170065671A1 (en) Methods for producing an oralsuspension of teichoplanin or teichoplanin analogs
WO1995033487A1 (en) Injectable formulations containing a desiccant
SI20411A (sl) Vodotopni praški za peroralno raztopino in njihova uporaba
CA2519869A1 (en) Taste-masking vehicle for coated oxazolidinone particles
EP3799861B1 (de) Pädiatrische suspensionsformulierung
EP3075377B1 (de) Orale zusammensetzungen umfassend pulverförmige pflanzenextrakte
SI20058A (sl) Farmacevtske oblike
KR20220161296A (ko) 포장체에 들어가는 함수 조성물
SI9400338A (en) Vancomycin hydrochloride suspensions for peroral use and for filling into soft ,gelatine capsules.
CZ11407U1 (cs) Farmaceutický prostředek uzpůsobený pro pediatrické podávání
KR20000050265A (ko) 아지스로마이신 경구 투여 제형을 포함하는 치료용 패키지